S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
Free Trial
TSE:NBLY

Neighbourly Pharmacy (NBLY) Stock Price, News & Analysis

→ 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad)
Free NBLY Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$18.24
▼
C$18.60
52-Week Range
N/A
Volume
816,808 shs
Average Volume
283,112 shs
Market Capitalization
C$835.51 million
P/E Ratio
N/A
Dividend Yield
0.98%
Price Target
C$20.93
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades
NBLY stock logo

About Neighbourly Pharmacy Stock (TSE:NBLY)

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

NBLY Stock News Headlines

March 23, 2024 | finanznachrichten.de
Neighbourly Pharmacy Inc.: Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital Partners
March 21, 2024 | finanznachrichten.de
Neighbourly Pharmacy Inc.: Neighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital Partners
April 19, 2024 | DTI (Ad)
Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
March 20, 2024 | finance.yahoo.com
Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital Partners
March 19, 2024 | finance.yahoo.com
Neighbourly Pharmacy Inc.'s (TSE:NBLY) largest shareholders are private equity firms with 50% ownership, individual investors own 36%
March 14, 2024 | finance.yahoo.com
Neighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital Partners
March 8, 2024 | marketwatch.com
Neighbourly Pharmacy Holders Approve Deal to go Private
March 8, 2024 | finance.yahoo.com
Neighbourly Obtains Shareholder Approval for Going Private Transaction with Persistence Capital Partners
April 19, 2024 | DTI (Ad)
Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
February 16, 2024 | ca.finance.yahoo.com
Neighbourly Pharmacy Inc. (NBLY.TO)
February 15, 2024 | finance.yahoo.com
When Will Neighbourly Pharmacy Inc. (TSE:NBLY) Breakeven?
February 13, 2024 | msn.com
Neighbourly Pharmacy Inc. Non-GAAP EPS of C$0.19, revenue of C$284M
February 13, 2024 | finance.yahoo.com
Neighbourly Announces Strong Third Quarter Results
February 12, 2024 | finance.yahoo.com
Neighbourly Announces Filing of Special Meeting Materials and Receipt of Interim Order in Respect of Go-Private Arrangement with Persistence Capital Partners
February 1, 2024 | finance.yahoo.com
Neighbourly Announces Timing of Third Quarter 2024 Earnings Release
January 23, 2024 | finance.yahoo.com
Neighbourly Appoints Maura Dyer as Senior Vice President, People and Culture
January 15, 2024 | marketwatch.com
Neighbourly Pharmacy Shares Rise 16% on Go-Private Deal
January 15, 2024 | marketwatch.com
Neighbourly Pharmacy Agrees to Go-Private Deal Worth C$415M
January 15, 2024 | msn.com
Persistence Capital Partners signs deal to take Neighbourly Pharmacy private
January 15, 2024 | finance.yahoo.com
Neighbourly Enters into Definitive Agreement to go Private with its Controlling Shareholder Persistence Capital Partners
December 20, 2023 | theglobeandmail.com
Closing Bell: Neighbourly Pharmacy Inc up on Wednesday (NBLY)
December 19, 2023 | finance.yahoo.com
Neighbourly Pharmacy's Market Cap Drops To CA$800m Leaving Insiders With Losses
December 18, 2023 | theglobeandmail.com
Persistence Capital Partners cuts buyout offer for Neighbourly Pharmacy
December 18, 2023 | marketwatch.com
Toronto Stocks Climb; Neighbourly Pharmacy Falls on Lowered Buyout Offer
December 18, 2023 | marketwatch.com
Neighbourly Pharmacy Shares Slide 12% on Lowered Buyout Price Proposal
December 18, 2023 | finance.yahoo.com
Neighbourly Provides Update on Proposal from Persistence Capital Partners
December 18, 2023 | finance.yahoo.com
Persistence Capital Partners Proposes Fully Financed Offer to Take Neighbourly Private at $18.50 per Share
See More Headlines
Receive NBLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
6/06/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Pharmaceutical Retailers
Sub-Industry
N/A
Current Symbol
TSE:NBLY
CUSIP
N/A
CIK
N/A
Web
neighbourlypharmacy.ca
Phone
416 309 9102
Fax
N/A
Employees
3,648
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$20.93
High Stock Price Target
C$28.00
Low Stock Price Target
C$18.50
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
C($0.73)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-32,700,000.00
Net Margins
-3.74%
Pretax Margin
N/A
Return on Equity
-5.34%
Return on Assets
0.74%

Debt

Debt-to-Equity Ratio
58.29
Current Ratio
1.14
Quick Ratio
0.75

Sales & Book Value

Annual Sales
C$874.61 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
31.16
Book Value
C$13.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
44,920,000
Free Float
N/A
Market Cap
C$835.51 million
Optionable
Not Optionable
Beta
0.29
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Skip Bourdo (Age 46)
    CEO & Director
    Comp: $604.17k
  • Mr. Billy Wong C.M.A.
    CPA, M.B.A., Chief Financial Officer
  • Mr. Jari Pekka Villanen (Age 53)
    Senior Vice President of Integration, Real Estate & Central Operations
    Comp: $307.48k
  • Mr. Steve Losty (Age 50)
    Chief Development Officer
    Comp: $302.15k
  • Ms. Maura Dyer
    Senior Vice President of People & Culture
  • Ms. Alicia Matthews-Kent
    Senior Vice President of Pharmacy Strategy & National Operations
  • Mr. Zev Zelman
    Corporate Secretary

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

NBLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Neighbourly Pharmacy stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares.
View NBLY analyst ratings or view top-rated stocks.

What is Neighbourly Pharmacy's stock price target for 2024?

5 analysts have issued 12 month price targets for Neighbourly Pharmacy's stock. Their NBLY share price targets range from C$18.50 to C$28.00. On average, they expect the company's stock price to reach C$20.93 in the next year.
View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts.

When is Neighbourly Pharmacy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024.
View our NBLY earnings forecast.

How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?

Neighbourly Pharmacy declared a quarterly dividend on Monday, November 20th. Shareholders of record on Tuesday, December 19th will be given a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 dividend on an annualized basis and a yield of ∞. The ex-dividend date of this dividend is Monday, November 20th.
Read our dividend analysis for NBLY.

Is Neighbourly Pharmacy a good dividend stock?

Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 0.98%.
Read our dividend analysis for NBLY.

How do I buy shares of Neighbourly Pharmacy?

Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NBLY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith